FMP

FMP

Enter

BTTX - Better Therapeutics,...

Financial Summary of Better Therapeutics, Inc.(BTTX), Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PD

photo-url-https://financialmodelingprep.com/image-stock/BTTX.png

Better Therapeutics, Inc.

BTTX

NASDAQ

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.

0.0078 USD

0.0004 (5.13%)

About

ceo

Mr. Frank L. Karbe

sector

Healthcare

industry

Biotechnology

website

https://www.bettertx.com

exchange

NASDAQ

Description

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Fran...

CIK

0001832415

ISIN

US08773T1043

CUSIP

08773T104

Address

548 Market Street

Phone

415 887 2311

Country

US

Employee

54

IPO Date

Mar 17, 2021

Summary

CIK

0001832415

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

08773T104

ISIN

US08773T1043

Country

US

Price

0.01

Beta

2

Volume Avg.

479.58k

Market Cap

425.22k

Shares

-

52-Week

0.005-1.35

DCF

0.04

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.01

P/B

-

Website

https://www.bettertx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest BTTX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep